Q3 2025 Prestige Consumer Healthcare Inc Earnings Call Transcript
Key Points
- Prestige Consumer Healthcare Inc (PBH) reported record quarterly sales and EPS, with net sales of $290 million, a 3% increase from the previous year.
- The company experienced strong international growth, particularly with the Hydralyte brand, and broad-based growth across nearly all North American categories.
- Earnings per share (EPS) increased by 15% in Q3, reaching a record $1.22, driven by strong sales growth and disciplined capital deployment.
- The company reduced its variable term loan debt balance to zero and improved its leverage ratio to 2.5 times, enhancing financial flexibility.
- Prestige Consumer Healthcare Inc (PBH) maintained strong free cash flow, enabling capital deployment options to enhance shareholder value, including share repurchases.
- The company faced supply chain constraints, particularly affecting the Clear Eyes brand, which impacted sales and required careful management of production levels.
- Cough and cold sales were lower than expected, and the company does not anticipate significant retailer reorders despite a slight increase in incident levels.
- Gross margin was slightly down in the first nine months due to expenses associated with expedited freight for Clear Eyes.
- The company is exposed to potential impacts from tariffs and inflation, which could affect future financial performance.
- Despite an increase in earnings guidance, the free cash flow guidance remained unchanged, indicating potential constraints in cash flow growth.
Thank you for standing by and welcome to Prestige Consumer Healthcare third quarter, 2025 earnings conference call. At this time, all participants are in a listen-only mode.
After the speaker presentation, there will be a question-and-answer session to ask a question. During the session. You will need to press star one on your telephone to remove yourself from the queue. You may press star 11 again.
I would now like to hand the call over to philip Terpolilli, Vice President, Investor Relations and Treasury.
Please go ahead.
Thanks operator and thank you to everyone who has joined today on the call with me are Ronald M. Lombardi, our Chairman, President and CEO. our CFO and COO on today's call, we'll review our third quarter, fiscal 2025 results, discuss our full year outlook and then take questions from analysts.
A slide presentation accompanies today's call can be accessed by visiting prestigeconsumerhealthcare
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
